Early events in ovarian oncogenesis

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  Cvetkovic, Dusica ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CATHEPSIN B; FENRETINIDE; K RAS PROTEIN; MYOD PROTEIN; ONCOPROTEIN; ORAL CONTRACEPTIVE AGENT; PROTEIN SERINE THREONINE KINASE; RETINOL BINDING PROTEIN; RETINOL DERIVATIVE; RNA DIRECTED DNA POLYMERASE; SCATTER FACTOR RECEPTOR; TELOMERASE; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN; ZINC FINGER PROTEIN;

ANTINEOPLASTIC ACTIVITY; CANCER GENETICS; CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; DISEASE ASSOCIATION; EARLY CANCER; ENZYME ACTIVITY; EPIGENETICS; EXPERIMENTAL MODEL; FEMALE; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; ONCOGENE; OVARY CANCER; PROTEIN METHYLATION; RETROSPECTIVE STUDY; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 4344707226     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.186/1477-7827-1-68     Document Type: Review

References (64)

1. Fox H: Pathology of early malignant change in the ovary. Int J Gynecol Pathol 1993, 12:153-155.
2. Ozols RF, Schwartz PE, Eifel PJ: Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. Cancer Principles and Practice of Oncology (Edited by: De Vita V T, Hellman Jr S and Rosenberg S A). Philadelphia-New York, Lippincott-Raven 1997, 1502-1534.
3. Dubeau L: The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol Oncol 1999, 72:437-442.
4. Society American Cancer: Cancer facts and figures. Atlanta, GA, American Cancer Society, Inc. 2003.
5. Bast R. C., Jr.: Status of tumor markers in ovarian cancer screening. J Clin Oncol 2003, 21:200-205.
6. Ozols RF, Daly MB, Klein-Szanto A, Hamilton TC, Bast R. C., Jr., Brewer MA: Specific keynote: chemoprevention of ovarian cancer: the journey begins. Gynecol Oncol 2003, 88:S59-66; discussion S67-70.
7. Kruk PA, Maines-Bandiera SL, Auersperg N: A simplified method to culture human ovarian surface epithelium. Lab Invest 1990, 63:132-136.
8. Auersperg N, Maines-Bandiera SL, Dyck HG: Ovarian carcinogenesis and the biology of ovarian surface epithelium. J Cell Physiol 1997, 173:261-265.
9. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC: Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer. Cancer Res 2003, 63:1389-1397.
10. Berchuck A, Kohler MF, Bast R. C., Jr.: Molecular genetic features of ovarian cancer. Prog Clin Biol Res 1996, 394:269-284.
11. Aunoble B, Sanches R, Didier E, Bignon YJ: Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol 2000, 16:567-576.
12. Havrilesky LJ, Berchuck A: Molecular alterations in sporadic ovarian cancer. Ovarian Cancer (Edited by: Rubin SC and Sutton GP). Philadelphia, Lippincott, Williams & Wilkins 2001, 22-42.
13. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
14. Aoki Y, Kawada N, Tanaka K: Early form of ovarian cancer originating in inclusion cysts. A case report. J Reprod Med 2000, 45:159-161.
15. Powell DE, Puls L, van Nagell J., Jr.: Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur? Hum Pathol 1992, 23:846-847.
16. Puls LE, Powell DE, DePriest PD, Gallion HH, Hunter JE, Kryscio RJ, van Nagell J. R., Jr.: Transition from benign to malignant epithelium in mucinous and serous ovarian cystadenocarcinoma. Gynecol Oncol 1992, 47:53-57.
17. Scully RE: Pathology of ovarian cancer precursors. J Cell Biochem Suppl 1995, 23:208-218.
18. Salazar H, Godwin AK, Daly MB, Laub PB, Hogan WM, Rosenblum N, Boente MP, Lynch HT, Hamilton TC: Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst 1996, 88:1810-1820.
19. McCluskey LL, Dubeau L: Biology of ovarian cancer. Curr Opin Oncol 1997, 9:465-470.
20. Catteau A, Morris JR: BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 2002, 12:359-371.
21. Cheng P, Schmutte C, Cofer KF, Felix JC, Yu MC, Dubeau L: Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis. Br J Cancer 1997, 75:396-402.
22. Wan M, Li WZ, Duggan BD, Felix JC, Zhao Y, Dubeau L: Telomerase activity in benign and malignant epithelial ovarian tumors. J Natl Cancer Inst 1997, 89:437-441.
23. Kruk PA, Godwin AK, Hamilton TC, Auersperg N: Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer. Gynecol Oncol 1999, 73:229-236.
24. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995, 55:2533-2536.
25. Fathalla MF: Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971, 2:163.
26. Riman T, Persson I, Nilsson S: Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) 1998, 49:695-707.
27. Whittemore AS, Harris R, Itnyre J: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992, 136:1212-1220.
28. Rodriguez GC, Walmer DK, Cline M, Krigman H, Lessey BA, Whitaker RS, Dodge R, Hughes CL: Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig 1998, 5:271-276.
29. Adams AT, Auersperg N: Transformation of cultured rat ovarian surface epithelial cells by Kirsten murine sarcoma virus. Cancer Res 1981, 41:2063-2072.
30. Nicosia SV, Johnson JH: Surface morphology of ovarian mesothelium (surface epithelium) and of other pelvic and extrapelvic mesothelial sites in the rabbit. Int J Gynecol Pathol 1984, 3:249-260.
31. Osterholzer HO, Streibel EJ, Nicosia SV: Growth effects of protein hormones on cultured rabbit ovarian surface epithelial cells. Biol Reprod 1985, 33:247-258.
32. Godwin AK, Testa JR, Handel LM, Liu Z, Vanderveer LA, Tracey PA, Hamilton TC: Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst 1992, 84:592-601.
33. Testa JR, Getts LA, Salazar H, Liu Z, Handel LM, Godwin AK, Hamilton TC: Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity. Cancer Res 1994, 54:2778-2784.
34. Abdollahi A, Getts LA, Sonoda G, Miller PD, Taguchi T, Godwin AK, Testa JR, Hamilton TC: Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells. J Soc Gynecol Investig 1999, 6:32-40.
35. Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC: LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J Biol Chem 2003, 278:6041-6049.
36. Roberts D, Williams SJ, Cvetkovic D, Weinstein JK, Godwin AK, Johnson SW, Hamilton TC: Decreased expression of retinol-binding proteins is associated with malignant transformation of the ovarian surface epithelium. DNA Cell Biol 2002, 21:11-19.
37. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira Y. Lopez R.: Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000, 92:475-480.
38. De Palo G, Veronesi U, Camerini T, Formelli F, Mascotti G, Boni C, Fosser V, Del Vecchio M, Campa T, Costa A, et al.: Can fenretinide protect women against ovarian cancer? J Natl Cancer Inst 1995, 87:146-147.
39. Cvetkovic D, Williams SJ, Hamilton TC: Loss of Cellular Retinol-binding Protein 1 Gene Expression in Microdissected Human Ovarian Cancer. Clin Cancer Res 2003, 9:1013-1020.
40. Heinonen PK, Kuoppala T, Koskinen T, Punnonen R: Serum vitamins A and E and carotene in patients with gynecologic cancer. Arch Gynecol Obstet 1987, 241:151-156.
41. Bertone ER, Hankinson SE, Newcomb PA, Rosner B, Willet WC, Stampfer MJ, Egan KM: A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes Control 2001, 12:83-90.
42. Yang DH, Smith ER, Cohen C, Wu H, Patriotis C, Godwin AK, Hamilton TC, Xu XX: Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer 2002, 94:2380-2392.
43. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX: Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene 1999, 18:3104-3113.
44. Capo-Chichi CD, Smith ER, Yang DH, Roland IH, Vanderveer L, Cohen C, Hamilton TC, Godwin AK, Xu XX: Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer 2002, 95:1802-1815.
45. Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA, Fiorica JV, Nicosia SV, Cheng JQ: Activation and Overexpression of Centrosome Kinase BTAK/Aurora-A in Human Ovarian Cancer. Clin Cancer Res 2003, 9:1420-1426.
46. Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM: K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 1991, 139:777-785.
47. Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J: K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 1997, 79:1581-1586.
48. Garrett AP, Lee KR, Colitti CR, Muto MG, Berkowitz RS, Mok SC: k-ras mutation may be an early event in mucinous ovarian tumorigenesis. Int J Gynecol Pathol 2001, 20:244-251.
49. Haas CJ, Diebold J, Hirschmann A, Rohrbach H, Lohrs U: In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential. Virchows Arch 1999, 434:117-120.
50. Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, Berkowitz RS, Mok SC, Gershenson DM: Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Cancer Res 2001, 61:7264-7267.
51. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001, 22:255-288.
52. Auersperg N, Ota T, Mitchell GW: Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Int J Gynecol Cancer 2002, 12:691-703.
53. Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, Roskelley CD: E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A 1999, 96:6249-6254.
54. Wong AS, Pelech SL, Woo MM, Yim G, Rosen B, Ehlen T, Leung PC, Auersperg N: Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis? Oncogene 2001, 20:1318-1328.
55. Iwabuchi H, Sakamoto M, Sakunaga H, Ma YY, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW: Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 1995, 55:6172-6180.
56. Smith DI: Transcriptional profiling develops molecular signatures for ovarian tumors. Cytometry 2002, 47:60-62.
57. Watson RH, Neville PJ, Roy W. J., Jr., Hitchcock A, Campbell IG: Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis. Oncogene 1998, 17:207-212.
58. Gallion HH, Powell DE, Morrow JK, Pieretti M, Case E, Turker MS, DePriest PD, Hunter JE, van Nagell J. R., Jr.: Molecular genetic changes in human epithelial ovarian malignancies. Gynecol Oncol 1992, 47:137-142.
59. Le T, Adolph A, Krepart GV, Lotocki R, Heywood MS: The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 2002, 85:351-355.
60. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, M Mills GB, Bast R. C., Jr., James CD, Couch FJ, Hartmann LC, Lillie J, Smith DI: Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 2001, 61:5895-5904.
61. Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J, Smith DI: Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 2002, 62:262-270.
62. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ: Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001, 61:3869-3876.
63. Sawiris GP, Sherman-Baust CA, Becker KG, Cheadle C, Teichberg D, Morin PJ: Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res 2002, 62:2923-2928.
64. Mills GB, Bast R. C., Jr., Srivastava S: Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics. J Natl Cancer Inst 2001, 93:1437-1439.